Aprea Therapeutics, Inc. (APRE)
NASDAQ: APRE · Real-Time Price · USD
1.750
-0.060 (-3.31%)
At close: Jun 6, 2025, 4:00 PM
1.830
+0.080 (4.57%)
After-hours: Jun 6, 2025, 5:23 PM EDT

Aprea Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Market Capitalization
10181818--
Market Cap Growth
-69.16%1.81%0.11%---
Enterprise Value
-10-7-6-12--
Last Close Price
1.753.294.706.62--
PS Ratio
8.1211.9030.11---
PB Ratio
0.620.870.960.65--
P/TBV Ratio
0.620.931.040.68--
Debt / Equity Ratio
----0.00-
Asset Turnover
0.050.060.02---
Quick Ratio
5.746.804.938.997.25-
Current Ratio
5.907.025.149.427.73-
Return on Equity (ROE)
-59.80%-66.66%-63.19%-294.69%--
Return on Assets (ROA)
-35.70%-38.39%-36.62%-53.71%--
Return on Capital (ROIC)
-40.49%-46.03%-42.77%-60.94%--
Earnings Yield
-145.47%-72.47%-81.35%-642.23%--
FCF Yield
-136.98%-75.90%-69.87%-142.58%--
Buyback Yield / Dilution
-54.69%-52.31%-118.31%-55.69%-0.72%-
Updated May 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q